Skandinaviska Enskilda Banken Ab (Publ) Axogen, Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$6.99 - $10.0 $248,529 - $355,550	35,555 Added 65.02%	90,241 $739,000
Q1 2022 May 11, 2022	SELL	$7.26 - $10.7 $197,079 - $290,462	-27,146 Reduced 33.17%	54,686 $434,000
Q3 2021 Nov 10, 2021	SELL	$15.23 - $21.72 $30,718 - $43,809	-2,017 Reduced 2.41%	81,832 $1.29 Million
Q2 2021 Aug 10, 2021	BUY	$17.8 - $23.5 $41,901 - $55,319	2,354 Added 2.89%	83,849 $1.81 Million
Q1 2021 May 14, 2021	SELL	$17.18 - $22.6 $148,469 - $195,309	-8,642 Reduced 9.59%	81,495 $1.65 Million
Q4 2020 Feb 11, 2021	BUY	$11.5 - $17.96 $223,456 - $348,980	19,431 Added 27.48%	90,137 $1.61 Million
Q3 2020 Nov 12, 2020	BUY	$10.62 - $13.12 $733,948 - $906,723	69,110 Added 4330.2%	70,706 $822,000
Q2 2020 Aug 13, 2020	BUY	$7.35 - $10.81 $11,730 - $17,252	1,596 New	1,596 $15,000

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $763M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.